NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品编号 06697999 持证商 SCHAPER & BRÜMMER GmbH & Co. KG 包装规格 100 St Packungsnorm N3 产品名 Esberitox Tabletten 剂型 Tabletten Pfl. Arzneimittel ja 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/produkt/esberitox-tabletten-100-st-06697999.html
产品名称：CLINDAMYCIN PHOSPHATE上市时间：04/26/2023NDA/ANDA/BLA:208767持证商：CADILANDC:68788-7990-6,72578-084-02,72578-084-03,53002-8371-1,70771-1414-2,70771-1414-3说明书：批准信：
产品名称：ZEJUL上市时间：04/26/2023NDA/ANDA/BLA:208447持证商：GLAXOSMITHKLINENDC:69656-103-30,69656-103-61说明书：httpS://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208447lbl.pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208447Orig1s000Ltr.pdf
产品名称：SPIRONOLACTONE上市时间：04/26/2023NDA/ANDA/BLA:205936持证商：ZYDUS PHARMSNDC:68382-660-10,68382-660-30,68382-661-10,68382-662-30,68382-662-06,70518-2384-0,70518-2384-2,70518-2385-0,70518-2386-0,68382-660-01,68382-661-06,68382-662-05,68382-662-16,0904-6927-61,51655-636-26,70771-1027-9,70771-1029-9,70518-...
产品名称：METAXALONE上市时间：04/26/2023NDA/ANDA/BLA:203695持证商：ACTAVIS LABS FL INCNDC:60760-093-60,60760-093-90,68788-7018-1,68788-7018-3,55700-911-90,68788-7018-0,45865-985-30,45865-985-90,50436-0449-1,50436-0449-2,50436-0449-3,80425-0131-2,0591-2341-01,60760-093-20,55700-911-30,80425-0131-3,63629-8014-1,636...
产品名称：VERSACLOZ上市时间：04/26/2023NDA/ANDA/BLA:203479持证商：TASMAN PHARMANDC:52817-601-38说明书：https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203479s000lbl.pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/203479Orig1s000ltr.pdf
产品名称：CLOZAPINE上市时间：04/26/2023NDA/ANDA/BLA:203039持证商：TEVA PHARMS USANDC:0093-5376-01,0093-5376-84,0093-5377-01,0093-5377-84说明书：https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203039Orig1s000lbl.pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203039Orig1s000ltr.pdf
产品名称：DUTASTERIDE上市时间：04/26/2023NDA/ANDA/BLA:202660持证商：AUROBINDO PHARMA LTDNDC:59651-021-30,59651-021-90说明书：https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=b32611f3-50ec-45bb-a671-ea10cec7829d&type=pdf批准信：
产品名称：DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE上市时间：04/26/2023NDA/ANDA/BLA:202509持证商：ANCHEN PHARMSNDC:10370-280-09,10370-280-11说明书：批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/202509Orig1s000ltr.pdf
产品名称：CLOZAPINE上市时间：04/26/2023NDA/ANDA/BLA:201824持证商：MYLANNDC:0378-3813-01,0378-3815-01,51079-288-04说明书：https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=976be6e3-a9db-49c6-9b02-1ab168cf17b1&type=pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/201824Orig1s000ltr.pdf
产品名称：LEMTRADA上市时间：04/26/2023NDA/ANDA/BLA:103948持证商：GENZYMENDC:58468-0357-1,58468-0357-3,58468-0200-1说明书：https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=6236b0bc-82e9-4447-9a78-f57d94770269&type=pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/alemmil050701L.htm
